Status:

UNKNOWN

Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn

Lead Sponsor:

Guangzhou Saliai Stem Cell Science and Technology Co. Ltd.

Conditions:

Ocular Corneal Burn

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

PHASE2

Brief Summary

Ocular chemical burn is one of the causes of vision loss in China, and there are no satisfactory treatment. Human umbilical cord mesenchymal stem cells(UC-MSCs) have the biological characteristics of ...

Eligibility Criteria

Inclusion

  • must be ocular burns including chemically burned or the thermally burned;
  • the subjects are willing to accept this research, and promise to coordinate with the researchers during the follow up period;
  • the subjects should abide by the laws and rules of the study.

Exclusion

  • the visual acuity is blind in any of the eye;
  • have corneal perforation or have the corneal perforation tendency;
  • have been accepted surgery on eyeball after trauma;
  • IOP\>=25 mmHg even after antiglaucoma;
  • have the history of other corneal disease or surgery;
  • have the history of radiotherapy or surgery in the eyeball;
  • associated with corneal ulcer or endoophthalmitis;
  • uncontrolled hypertension(\>=150/95 mmHg);
  • abnormal liver and renal function;
  • the pregnant women.

Key Trial Info

Start Date :

January 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03237442

Start Date

January 1 2018

End Date

June 30 2019

Last Update

August 2 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Jinan University

Guangzhou, Guangdong, China